Greg Troiano
41Patents
18h-index
24Co-inventors
77Inventor score
Filing activity: Jun 16, 2009 → Sep 7, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8613951B2 | Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same | Emerging Cross-Sectional Technologies | 136 | Active |
| US8420123B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 113 | Active |
| US8617608B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 105 | Active |
| US8609142B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 102 | Active |
| US8613954B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 100 | Active |
| US8603534B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 83 | Active |
| US8603535B2 | Stable formulations for lyophilizing therapeutic particles | Emerging Cross-Sectional Technologies | 80 | Active |
| US8663700B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 77 | Active |
| US8637083B2 | Stable formulations for lyophilizing therapeutic particles | Emerging Cross-Sectional Technologies | 76 | Active |
| US8652528B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 73 | Active |
| US8211473B2 | Stable formulations for lyophilizing therapeutic particles | Emerging Cross-Sectional Technologies | 62 | Active |
| US8206747B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 62 | Active |
| US8318211B2 | Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same | Human Necessities | 44 | Active |
| US8318208B1 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 43 | Active |
| US8293276B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 37 | Active |
| US8357401B2 | Stable formulations for lyophilizing therapeutic particles | Emerging Cross-Sectional Technologies | 28 | Active |
| US8518963B2 | Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers | Physics | 21 | Active |
| US8623417B1 | Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same | Emerging Cross-Sectional Technologies | 18 | Active |
| US10080723B2 | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same | Performing Operations; Transporting | 7 | Active |
| US9895378B2 | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using the same | Human Necessities | 4 | Active |
| US9877923B2 | Process for preparing therapeutic nanoparticles | Human Necessities | 4 | Active |
| US9579284B2 | Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same | Emerging Cross-Sectional Technologies | 3 | Active |
| US8912212B2 | Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers | Physics | 3 | Active |
| US10071100B2 | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using the same | Human Necessities | 2 | Active |
| US9393310B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.